Colgate-Palmolive (CL) to Release Earnings on Friday

Colgate-Palmolive (NYSE:CL) will be releasing its earnings data before the market opens on Friday, April 26th. Analysts expect Colgate-Palmolive to post earnings of $0.82 per share for the quarter. Colgate-Palmolive has set its FY 2024 guidance at EPS.Investors interested in listening to the company’s conference call can do so using this link.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, January 26th. The company reported $0.87 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.85 by $0.02. Colgate-Palmolive had a return on equity of 509.75% and a net margin of 11.82%. The firm had revenue of $4.95 billion for the quarter, compared to the consensus estimate of $4.89 billion. During the same period in the prior year, the company posted $0.77 earnings per share. The company’s quarterly revenue was up 6.9% on a year-over-year basis. On average, analysts expect Colgate-Palmolive to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Colgate-Palmolive Price Performance

NYSE CL opened at $88.87 on Thursday. The company has a debt-to-equity ratio of 8.59, a quick ratio of 0.71 and a current ratio of 1.11. The company has a market capitalization of $73.05 billion, a price-to-earnings ratio of 31.97, a PEG ratio of 3.32 and a beta of 0.42. The stock has a 50-day moving average of $87.40 and a 200 day moving average of $81.25. Colgate-Palmolive has a one year low of $67.62 and a one year high of $90.37.

Colgate-Palmolive Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Monday, April 22nd will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.25%. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.48. The ex-dividend date is Friday, April 19th. Colgate-Palmolive’s payout ratio is presently 71.94%.

Analyst Ratings Changes

Several equities analysts have recently weighed in on CL shares. The Goldman Sachs Group assumed coverage on Colgate-Palmolive in a report on Friday, March 1st. They set a “buy” rating and a $93.00 price target on the stock. Stifel Nicolaus boosted their price target on Colgate-Palmolive from $89.00 to $94.00 and gave the company a “buy” rating in a research note on Wednesday, April 10th. JPMorgan Chase & Co. increased their price objective on shares of Colgate-Palmolive from $88.00 to $90.00 and gave the stock an “overweight” rating in a research note on Thursday, January 18th. Barclays boosted their target price on shares of Colgate-Palmolive from $82.00 to $84.00 and gave the company an “equal weight” rating in a research report on Friday, April 12th. Finally, Evercore ISI increased their price target on shares of Colgate-Palmolive from $90.00 to $96.00 and gave the stock an “outperform” rating in a research report on Monday, April 8th. Three analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $89.50.

Insider Activity at Colgate-Palmolive

In related news, insider Jennifer Daniels sold 61,633 shares of the company’s stock in a transaction on Thursday, February 1st. The shares were sold at an average price of $83.93, for a total transaction of $5,172,857.69. Following the completion of the transaction, the insider now owns 57,948 shares in the company, valued at $4,863,575.64. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In related news, insider Jennifer Daniels sold 61,633 shares of the stock in a transaction that occurred on Thursday, February 1st. The stock was sold at an average price of $83.93, for a total transaction of $5,172,857.69. Following the completion of the transaction, the insider now directly owns 57,948 shares of the company’s stock, valued at $4,863,575.64. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director C Martin Harris sold 2,760 shares of Colgate-Palmolive stock in a transaction that occurred on Wednesday, January 31st. The stock was sold at an average price of $84.50, for a total value of $233,220.00. Following the completion of the sale, the director now directly owns 19,272 shares in the company, valued at approximately $1,628,484. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 232,371 shares of company stock valued at $19,505,099. 0.37% of the stock is owned by company insiders.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.